Vivos Therapeutics Inc. (VVOS)
5.19
0.13 (2.57%)
At close: Jan 15, 2025, 1:38 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -1.12 | -0.41 | -2.35 | -12.2 | -10.24 | -12.15 |
| PS Ratio | 1.10 | 0.58 | 2.83 | 8.24 | 9.79 | 27.38 |
| PB Ratio | 36.91 | 1.93 | 1.87 | 6.36 | -37.91 | 21.51 |
| P/FCF Ratio | -1.19 | -0.45 | -2.63 | -18.55 | -20.23 | -15.82 |
| P/OCF Ratio | -1.27 | -0.47 | -3.04 | -18.95 | -20.89 | -19.54 |
| OCF/S Ratio | -0.87 | -1.22 | -0.93 | -0.43 | -0.47 | -1.4 |
| Debt / Equity Ratio | 4.85 | 0.50 | 0.06 | 0.08 | -1.26 | 0.14 |
| Quick Ratio | 0.34 | 0.80 | 3.64 | 2.61 | 0.19 | 0.93 |
| Current Ratio | 0.34 | 0.80 | 3.64 | 2.61 | 0.22 | 0.93 |
| Asset Turnover | 1.29 | 1.17 | 0.50 | 0.52 | 1.51 | 0.46 |
| Interest Coverage | n/a | n/a | -1.39K | -90.08 | -76.72 | -80.95 |
| Return on Equity (ROE) | -33.05 | -4.72 | -0.79 | -0.52 | 3.70 | -1.77 |
| Return on Assets (ROA) | -1.27 | -1.65 | -0.6 | -0.35 | -1.44 | -1.04 |
| Return on Capital (ROIC) | -5.03 | -3.62 | -0.74 | -0.5 | 6.86 | -1.38 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 59.93% | 62.52% | 74.65% | 79.69% | 75.99% | 71.48% |
| Net Profit Margin | -98.42% | -141.41% | -120.18% | -67.52% | -95.6% | -225.25% |
| Pretax Profit Margin | -98.42% | -148.81% | -120.15% | -92.28% | -94.39% | -222.54% |
| Operating Profit Margin | -125.32% | -156.21% | -115.32% | -66.65% | -92.84% | -219.82% |
| FCF Margin | -92.38% | -128% | -107.38% | -44.39% | -48.42% | -173.1% |
| EBITDA Margin | -120.82% | -152.03% | -115.73% | -86.04% | -86.59% | -203.72% |